AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32110819 — intervention group
Group type: COMPARATOR
Intervention: Control Group-1 (no antacid)
Number of subjects: 24
Study 32110819 — intervention group
Group type: COMPARATOR
Intervention: Control Group-2 (no food)
Number of subjects: 24
Study 34001667 — intervention group
Group type: EXPERIMENTAL
Intervention: PRN 0.5 mg conbercept intravitreal injections
Number of subjects: 248
Study 34001667 — intervention group
Group type: COMPARATOR
Intervention: Laser photocoagulation followed by PRN sham intravitreal injections
Number of subjects: 248
Study 34001667 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch to conbercept in the extension study
Number of subjects: 248
Study 33882139 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (FV) Duraphat
Number of subjects: 16
Study 33882139 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltrant (RI) Icon
Number of subjects: 16
Study 33882139 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive system (AS) Scotchbond
Number of subjects: 16
Study 33882139 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence-based methods (DIAGNOdent, DIAGNOdent pen, VistaProof fluorescence camera)
Number of subjects: 16
Study 33882139 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16
Study 35739438 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency needle plus stiff pigtail wire transseptal system
Number of subjects: 161
Study 35739438 — intervention group
Group type: COMPARATOR
Intervention: Conventional transseptal access
Number of subjects: 161
Study 35739438 — intervention group
Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 161
Study 32978755 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 140
Study 32978755 — intervention group
Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 140
Study 35639660 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 195
Study 35639660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 33323480 — intervention group
Group type: EXPERIMENTAL
Intervention: FES‐cycling (60 min >5 days/week plus usual care rehabilitation)
Number of subjects: 162
Study 33323480 — intervention group
Group type: COMPARATOR
Intervention: Usual care rehabilitation alone
Number of subjects: 162
Study 36364735 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific collagen peptide preparation (test group; n = 20)
Number of subjects: 39
Study 36364735 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo group; n = 19)
Number of subjects: 39
Study 33105594 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode Laser Therapy
Number of subjects: 0
Study 33105594 — intervention group
Group type: COMPARATOR
Intervention: CO2 Laser Therapy
Number of subjects: 0
Study 34348704 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee sleeve worn for 6 weeks, at least 1 hour daily.
Number of subjects: 34
Study 34348704 — intervention group
Group type: COMPARATOR
Intervention: Control group (no knee sleeve).
Number of subjects: 34
Study 33177477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 18
Study 33177477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 34625826 — intervention group
Group type: EXPERIMENTAL
Intervention: High-impact step aerobics (SA)
Number of subjects: 69
Study 34625826 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity resistance training (RT)
Number of subjects: 69
Study 34625826 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment control (CON)
Number of subjects: 69
Study 32388721 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening spot urine sample
Number of subjects: 101
Study 32388721 — intervention group
Group type: EXPERIMENTAL
Intervention: First morning spot urine sample
Number of subjects: 101
Study 32388721 — intervention group
Group type: EXPERIMENTAL
Intervention: Second morning spot urine sample
Number of subjects: 101
Study 34648931 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive interval CRS
Number of subjects: 8085
Study 34648931 — intervention group
Group type: COMPARATOR
Intervention: Open interval CRS
Number of subjects: 8085
Study 34242497 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin (140 mg silymarin capsules thrice daily)
Number of subjects: 17
Study 33145979 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits with health education on Enterobius vermicularis for 6 months
Number of subjects: 38
Study 33145979 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38
Study 33837787 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored recommendations with a brochure and a 30 min consultation by a trained nurse.
Number of subjects: 955
Study 33837787 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 955
Study 34487062 — intervention group
Group type: EXPERIMENTAL
Intervention: cONS (energy-dense pediatric oral nutritional supplements)
Number of subjects: 34
Study 34487062 — intervention group
Group type: COMPARATOR
Intervention: sONS (standard oral nutritional supplements)
Number of subjects: 34
Study 34487062 — intervention group
Group type: EXPERIMENTAL
Intervention: cONS
Number of subjects: 34
Study 34487062 — intervention group
Group type: EXPERIMENTAL
Intervention: cONS and sONS
Number of subjects: 34
Study 32648396 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-nape-acupuncture combined with hyperbaric oxygen therapy (ENA+HBOT)
Number of subjects: 78
Study 32648396 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 78
Study 33006057 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Pep-12 dietary supplementation (90 mg daily for 90 days)
Number of subjects: 0
Study 33006057 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33135666 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 3D virtual reality and horticultural therapy (9-week intervention)
Number of subjects: 106
Study 36149436 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct composite restoration without a base (Palfique LX5, Tokuyama Dental Corp Inc, Tokyo, Japan)
Number of subjects: 40
Study 36149436 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct composite restoration with a flowable composite liner (Estelite Flow Quick ‐High Flow, Tokuyama Dental Corp Inc)
Number of subjects: 40
Study 36149436 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct‐indirect composite restoration bonded with flowable composite
Number of subjects: 40
Study 36149436 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect restoration bonded with flowable composite
Number of subjects: 40
Study 36149436 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 40
Study 34535047 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin (100 mcg)
Number of subjects: 300
Study 34535047 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin (10 IU)
Number of subjects: 300
Study 32073384 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including audit and feedback reports for family physicians and educational materials for patients
Number of subjects: 0
Study 34616147 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty (PVP)
Number of subjects: 163
Study 34616147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting intra‐spinal canal cement leakage
Number of subjects: 163
Study 32552430 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric training of the tibialis anterior (TA) at short muscle-tendon unit length (S-group)
Number of subjects: 13
Study 32552430 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric training of the tibialis anterior (TA) at long muscle-tendon unit length (L-group)
Number of subjects: 13
Study 32552430 — intervention group
Group type: COMPARATOR
Intervention: Both groups (S-group and L-group)
Number of subjects: 13
Study 36231510 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 26
Study 33820931 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitavastatin + Ezetimibe
Number of subjects: 1429
Study 33820931 — intervention group
Group type: COMPARATOR
Intervention: Pitavastatin monotherapy
Number of subjects: 1429
Study 34275725 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace Vocal Health Promotion Program (WVHPP)
Number of subjects: 29
Study 34275725 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study 33435839 — intervention group
Group type: EXPERIMENTAL
Intervention: JuxtaCures™ device
Number of subjects: 40
Study 33435839 — intervention group
Group type: COMPARATOR
Intervention: Short stretch bandaging
Number of subjects: 40
Study 32916413 — intervention group
Group type: EXPERIMENTAL
Intervention: PM1 exposure
Number of subjects: 6740
Study 32916413 — intervention group
Group type: COMPARATOR
Intervention: PM2.5 exposure
Number of subjects: 6740
Study 35896419 — intervention group
Group type: EXPERIMENTAL
Intervention: Young Mania Rating Scale (YMRS)
Number of subjects: 2988
Study 35896419 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in CGI-S by 1 point
Number of subjects: 2988
Study 35896419 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in CGI-S by 2 points
Number of subjects: 2988
Study 34260591 — intervention group
Group type: EXPERIMENTAL
Intervention: Household playspace (HPS)
Number of subjects: 100
Study 34260591 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 32545051 — intervention group
Group type: EXPERIMENTAL
Intervention: High category stress symptoms
Number of subjects: 270
Study 32545051 — intervention group
Group type: EXPERIMENTAL
Intervention: High category anxiety symptoms
Number of subjects: 270
Study 32545051 — intervention group
Group type: EXPERIMENTAL
Intervention: High category depressive symptoms
Number of subjects: 270
Study 32545051 — intervention group
Group type: EXPERIMENTAL
Intervention: High category stress symptoms by gender
Number of subjects: 270
Study 32545051 — intervention group
Group type: EXPERIMENTAL
Intervention: High category anxiety symptoms by gender
Number of subjects: 270
Study 32545051 — intervention group
Group type: EXPERIMENTAL
Intervention: High category depressive symptoms by gender
Number of subjects: 270
Study 616788789 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated counseling (two sessions of group counseling and one session of individual counseling)
Number of subjects: 162
Study 616788789 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counseling (three sessions of two hours of group counseling with one week intervals)
Number of subjects: 162
Study 616788789 — intervention group
Group type: COMPARATOR
Intervention: Normal education (control)
Number of subjects: 162
Study 36127087 — intervention group
Group type: EXPERIMENTAL
Intervention: ISPOCD analogue test
Number of subjects: 0
Study 36127087 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindmore digital test
Number of subjects: 0
Study 36127087 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Depression Scale‐15
Number of subjects: 0
Study 36127087 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified System Usability Scale
Number of subjects: 0
Study 36127087 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish Quality of Recovery Scale
Number of subjects: 0
Study 33813836 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 2638
Study 36376468 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomous sensory meridian response (ASMR)
Number of subjects: 76
Study 36376468 — intervention group
Group type: EXPERIMENTAL
Intervention: Binaural beats (BB)
Number of subjects: 76
Study 36376468 — intervention group
Group type: EXPERIMENTAL
Intervention: ASMR
Number of subjects: 76
Study 36376468 — intervention group
Group type: COMPARATOR
Intervention: BB
Number of subjects: 76
Study 34983628 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on Health Action Process Approach (HAPA) for 3 months
Number of subjects: 248
Study 33011502 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracervical anaesthesia combined with hysteroscopic fundal infiltration with anaesthetics
Number of subjects: 96
Study 33011502 — intervention group
Group type: COMPARATOR
Intervention: Paracervical anaesthesia combined with hysteroscopic fundal infiltration with saline
Number of subjects: 96
Study 35039529 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem cells in fibrin glue
Number of subjects: 24
Study 35039529 — intervention group
Group type: COMPARATOR
Intervention: Normal saline/fibrin glue mixture
Number of subjects: 24
Study 35039529 — intervention group
Group type: COMPARATOR
Intervention: Normal saline only
Number of subjects: 24
Study 33258417 — intervention group
Group type: EXPERIMENTAL
Intervention: HIT
Number of subjects: 20
Study 33258417 — intervention group
Group type: EXPERIMENTAL
Intervention: Load Carriage-HIT (LCHIT)
Number of subjects: 20
Study 32627083 — intervention group
Group type: EXPERIMENTAL
Intervention: RSPO practices adoption
Number of subjects: 723
Study 32627083 — intervention group
Group type: COMPARATOR
Intervention: Non-adoption of RSPO practices
Number of subjects: 723
Study 36352479 — intervention group
Group type: EXPERIMENTAL
Intervention: Job retention vocational rehabilitation delivered by health service occupational therapists trained in the Workwell intervention.
Number of subjects: 0
Study 36352479 — intervention group
Group type: EXPERIMENTAL
Intervention: Workwell training for therapists.
Number of subjects: 0
Study 36352479 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-structured interviews with trial participants, employers, therapists, and therapy service managers.
Number of subjects: 0
Study 34218987 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsified-high-fat meal with fine lipid droplet size (FE)
Number of subjects: 16
Study 34218987 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsified-high-fat meal with coarse lipid droplet size (CE)
Number of subjects: 16
Study 34218987 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meal (LF)
Number of subjects: 16
Study 33338056 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise programme
Number of subjects: 61
Study 33338056 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 61
Study 35063228 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 g of protein/amino acids per kg body weight per day
Number of subjects: 42
Study 35063228 — intervention group
Group type: COMPARATOR
Intervention: 1.2 g of protein/amino acids per kg body weight per day
Number of subjects: 42
Study 34768623 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 1111
Study 34768623 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 1111
Study 34768623 — intervention group
Group type: COMPARATOR
Intervention: Bioabsorbable vascular scaffold/stents (BVS)
Number of subjects: 1111
Study 34236130 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher pre-HD serum phosphate (per 1 mg/dl)
Number of subjects: 969
Study 34236130 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of pre-HD serum phosphate
Number of subjects: 969
Study 34236130 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-HD serum phosphate (exploratory models)
Number of subjects: 969
Study 34518310 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 1217389 (64 mg twice daily) with weekly paclitaxel (90 mg/m2)
Number of subjects: 75
Study 34518310 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel monotherapy
Number of subjects: 75
Study 36127832 — intervention group
Group type: EXPERIMENTAL
Intervention: Novaloc attachment system
Number of subjects: 10
Study 36127832 — intervention group
Group type: COMPARATOR
Intervention: Locator attachment system
Number of subjects: 10
Study 36116523 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor induction within the first 15 to 20 hours after prelabor rupture of membranes
Number of subjects: 4742
Study 36116523 — intervention group
Group type: EXPERIMENTAL
Intervention: Labor induction within the first 30 to 36 hours after prelabor rupture of membranes
Number of subjects: 4742
Study 36116523 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 4742
Study 34427247 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafluprost 0.0015% (TP)
Number of subjects: 30
Study 34427247 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost 0.005% (LP)
Number of subjects: 30
Study 32314932 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-ultrasound and ultrasound fusion targeted biopsy
Number of subjects: 194
Study 35636794 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 weeks of training with the interactive training device
Number of subjects: 40
Study 35636794 — intervention group
Group type: COMPARATOR
Intervention: Usual physiotherapy care
Number of subjects: 40
Study 32943128 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised dietary advice (PDA)
Number of subjects: 81
Study 32943128 — intervention group
Group type: COMPARATOR
Intervention: General advice (GA)
Number of subjects: 81
Study 32943128 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA (visitors)
Number of subjects: 81
Study 32943128 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA (non-visitors)
Number of subjects: 81
Study 36088834 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle group intervention
Number of subjects: 401
Study 36088834 — intervention group
Group type: COMPARATOR
Intervention: Brief psychoeducational intervention
Number of subjects: 401
Study 33227548 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month DAPT
Number of subjects: 2016
Study 33227548 — intervention group
Group type: COMPARATOR
Intervention: ≥12-month DAPT
Number of subjects: 2016
Study 36361384 — intervention group
Group type: EXPERIMENTAL
Intervention: Shinrin-Yoku (Forest Bathing) intervention, 3-hour guided session
Number of subjects: 56
Study 36361384 — intervention group
Group type: COMPARATOR
Intervention: Control group (day off from clinical duties)
Number of subjects: 56
Study 36361384 — intervention group
Group type: EXPERIMENTAL
Intervention: Shinrin-Yoku (Forest Bathing) intervention
Number of subjects: 56
Study 34043924 — intervention group
Group type: EXPERIMENTAL
Intervention: WMTARB (Word Memory Test Arabic)
Number of subjects: 63
Study 34043924 — intervention group
Group type: EXPERIMENTAL
Intervention: TOMM (Test of Memory Malingering)
Number of subjects: 63
Study 34043924 — intervention group
Group type: COMPARATOR
Intervention: WMTARB
Number of subjects: 63
Study 33285389 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (Ω3)
Number of subjects: 38
Study 33285389 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual family psychoeducational psychotherapy (IF-PEP)
Number of subjects: 38
Study 33285389 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Omega-3 and IF-PEP
Number of subjects: 38
Study 33285389 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 38
Study 33238965 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe depressive symptoms reported by 16.35% (n=206) of participants.
Number of subjects: 1260
Study 33238965 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate depressive symptoms reported by 29.68% (n=374) of participants.
Number of subjects: 1260
Study 33238965 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adolescents (16 years and above) reported higher prevalence of depressive symptoms.
Number of subjects: 1260
Study 33238965 — intervention group
Group type: EXPERIMENTAL
Intervention: Family relationships and social support associated with lower levels of depressive symptoms.
Number of subjects: 1260
Study 33238965 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological wellbeing measures (self-concept and self-esteem) associated with lower levels of depressive symptoms.
Number of subjects: 1260
Study 33238965 — intervention group
Group type: EXPERIMENTAL
Intervention: Hopelessness associated with higher levels of depressive symptoms.
Number of subjects: 1260
Study 34286472 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (cholecalciferol 100,000 UI per 10 days over 1 month)
Number of subjects: 31
Study 34286472 — intervention group
Group type: COMPARATOR
Intervention: Low-dose vitamin D (ergocalciferol 400 UI/days over 1 month)
Number of subjects: 31
Study 32773524 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Fidelity Patient Simulation (HFPS)
Number of subjects: 0
Study 32773524 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Simulation
Number of subjects: 0
Study 32773524 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face Clinical Group (Control)
Number of subjects: 0
Study 32165407 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-guided gallbladder drainage (EUS-GBD)
Number of subjects: 80
Study 32165407 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous cholecystostomy (PT-GBD)
Number of subjects: 80
Study 32407179 — intervention group
Group type: EXPERIMENTAL
Intervention: α‐LA + Faradic
Number of subjects: 100
Study 32407179 — intervention group
Group type: EXPERIMENTAL
Intervention: Faradic
Number of subjects: 100
Study 32407179 — intervention group
Group type: EXPERIMENTAL
Intervention: α‐LA
Number of subjects: 100
Study 32407179 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study 34202935 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice frame
Number of subjects: 1012
Study 34202935 — intervention group
Group type: COMPARATOR
Intervention: Default frame (opt-in, opt-out)
Number of subjects: 1012
Study 34202935 — intervention group
Group type: COMPARATOR
Intervention: Enhanced choice frame
Number of subjects: 1012
Study 34202935 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall satisfaction and regret across frames
Number of subjects: 1012
Study 34202935 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived autonomy (behavioral control)
Number of subjects: 1012
Study 34202935 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of control
Number of subjects: 1012
Study 34202935 — intervention group
Group type: EXPERIMENTAL
Intervention: Opting for genetic testing between disease scenarios
Number of subjects: 1012
Study 34932886 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention for firstborn children
Number of subjects: 117